Sorry, but nothing matched your search terms. Please try again with some different keywords.
Nothing Found
- Weekly Market Review – September 21, 2024
- Weekly Market Review – September 14, 2024
- ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
- Structure patches up holes in share price after GLP-1 linked to 6% weight loss
- ASCO: ConcertAI announces Nvidia partnership, launches new AI tools
- Arrowhead fortifies position in tight Ionis race, with RNAi med lowering triglycerides in phase 3
- Pharma awaits Fed relief with $1T in firepower to spend on biotech innovation: report
- BD claims Edwards’ hospital monitoring portfolio for $4.2B
- Rapport talks up $122M IPO to support proof-of-concept epilepsy trials
- Lilly gilds neuro pipeline, paying QurAlis $45M for preclinical ALS, dementia prospect